ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency

Clinical trial NCT06462547 · RECRUITING

Trial details

NCT number: NCT06462547
Sponsor: Inozyme Pharma
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gene Mutations Pseudoxanthoma Elasticum Arterial Calcification Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency Autosomal Recessive Hypophosphatemic Rickets Type 2

Start date: 2024-06-19
Primary completion: 2030-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.